The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III)
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable qua...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Pain |
Subjects: | |
Online Access: | http://www.indianjpain.org/article.asp?issn=0970-5333;year=2019;volume=33;issue=4;spage=30;epage=36;aulast=Ramanjulu |
_version_ | 1818892718442545152 |
---|---|
author | Raghavendra Ramanjulu Raghu S Thota Arif Ahmed Parmanand Jain Sushma Bhatnagar Naveen Salins Aparna Chatterjee Dipasri Bhattacharya |
author_facet | Raghavendra Ramanjulu Raghu S Thota Arif Ahmed Parmanand Jain Sushma Bhatnagar Naveen Salins Aparna Chatterjee Dipasri Bhattacharya |
author_sort | Raghavendra Ramanjulu |
collection | DOAJ |
description | The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each subdraft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care members. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on the use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus it is not recommended. |
first_indexed | 2024-12-19T18:01:09Z |
format | Article |
id | doaj.art-1ee3b17b8c674fdeab7d9590ee390167 |
institution | Directory Open Access Journal |
issn | 0970-5333 |
language | English |
last_indexed | 2024-12-19T18:01:09Z |
publishDate | 2019-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Indian Journal of Pain |
spelling | doaj.art-1ee3b17b8c674fdeab7d9590ee3901672022-12-21T20:11:40ZengWolters Kluwer Medknow PublicationsIndian Journal of Pain0970-53332019-01-01334303610.4103/ijpn.ijpn_82_19The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III)Raghavendra RamanjuluRaghu S ThotaArif AhmedParmanand JainSushma BhatnagarNaveen SalinsAparna ChatterjeeDipasri BhattacharyaThe Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each subdraft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care members. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on the use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus it is not recommended.http://www.indianjpain.org/article.asp?issn=0970-5333;year=2019;volume=33;issue=4;spage=30;epage=36;aulast=Ramanjulubone painbreakthrough paincancer pain management guidelinescancer pain managementcancer pain special interest groupindian society for study of painopioidswho analgesic ladder |
spellingShingle | Raghavendra Ramanjulu Raghu S Thota Arif Ahmed Parmanand Jain Sushma Bhatnagar Naveen Salins Aparna Chatterjee Dipasri Bhattacharya The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III) Indian Journal of Pain bone pain breakthrough pain cancer pain management guidelines cancer pain management cancer pain special interest group indian society for study of pain opioids who analgesic ladder |
title | The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III) |
title_full | The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III) |
title_fullStr | The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III) |
title_full_unstemmed | The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III) |
title_short | The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III) |
title_sort | indian society for study of pain cancer pain special interest group guidelines on pharmacological management of cancer pain part iii |
topic | bone pain breakthrough pain cancer pain management guidelines cancer pain management cancer pain special interest group indian society for study of pain opioids who analgesic ladder |
url | http://www.indianjpain.org/article.asp?issn=0970-5333;year=2019;volume=33;issue=4;spage=30;epage=36;aulast=Ramanjulu |
work_keys_str_mv | AT raghavendraramanjulu theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT raghusthota theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT arifahmed theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT parmanandjain theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT sushmabhatnagar theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT naveensalins theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT aparnachatterjee theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT dipasribhattacharya theindiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT raghavendraramanjulu indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT raghusthota indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT arifahmed indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT parmanandjain indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT sushmabhatnagar indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT naveensalins indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT aparnachatterjee indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii AT dipasribhattacharya indiansocietyforstudyofpaincancerpainspecialinterestgroupguidelinesonpharmacologicalmanagementofcancerpainpartiii |